Pharmaco-fUS for Characterizing Drugs for Alzheimer’s Disease – The Case of THN201, a Drug Combination of Donepezil Plus Mefloquine

Overview of attention for article published in Frontiers in Neuroscience, August 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 5 news outlets

twitter: 16 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 18 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 21 X posts from 16 X users, with an upper bound of 87,836 followers.

RT @ConnexinPapers: Pharmaco-fUS for Characterizing Drugs for Alzheimer's Disease - The Case of THN201, a Drug Combination of Donepezil Plu…

20 Sep 2020

Reply Repost Favourite

RT @ConnexinPapers: Pharmaco-fUS for Characterizing Drugs for Alzheimer's Disease - The Case of THN201, a Drug Combination of Donepezil Plu…

11 Sep 2020

Reply Repost Favourite

RT @ConnexinPapers: Pharmaco-fUS for Characterizing Drugs for Alzheimer's Disease - The Case of THN201, a Drug Combination of Donepezil Plu…

10 Sep 2020

Reply Repost Favourite

Pharmaco-fUS for Characterizing Drugs for Alzheimer's Disease - The Case of THN201, a Drug Combination of Donepezil Plus Mefloquine. https://t.co/9hQ1qwWz0S

10 Sep 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 17 additional X posts.